Radwanski E - Search Results

1

Comparison of 4- and 24-hour intravenous infusion schedules for granulocyte-macrophage colony-stimulating factor.

Wong L, Taylor CW, Radwanski E, Hersh EM, Salmon SE. Wong L, et al. Among authors: radwanski e. J Immunother Emphasis Tumor Immunol. 1995 Jul;18(1):57-65. doi: 10.1097/00002371-199507000-00008. J Immunother Emphasis Tumor Immunol. 1995. PMID: 8535572 Clinical Trial. No abstract available.

2

Clinical, hematologic, and immunologic effects of interleukin-10 in humans.

Fuchs AC, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, Angel JB, Kennedy JS, Rabson AR, Radwanski E, Affrime MB, Cutler DL, Grint PC, Dinarello CA. Fuchs AC, et al. Among authors: radwanski e. J Clin Immunol. 1996 Sep;16(5):291-303. doi: 10.1007/BF01541395. J Clin Immunol. 1996. PMID: 8886999 Clinical Trial.

3

Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers.

Huhn RD, Radwanski E, Gallo J, Affrime MB, Sabo R, Gonyo G, Monge A, Cutler DL. Huhn RD, et al. Among authors: radwanski e. Clin Pharmacol Ther. 1997 Aug;62(2):171-80. doi: 10.1016/S0009-9236(97)90065-5. Clin Pharmacol Ther. 1997. PMID: 9284853 Clinical Trial.

4

Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers.

Huhn RD, Radwanski E, O'Connell SM, Sturgill MG, Clarke L, Cody RP, Affrime MB, Cutler DL. Huhn RD, et al. Among authors: radwanski e. Blood. 1996 Jan 15;87(2):699-705. Blood. 1996. PMID: 8555493 Free article. Clinical Trial.

5

Effects of single intravenous doses of recombinant human interleukin-10 on subsets of circulating leukocytes in humans.

Huhn RD, Pennline K, Radwanski E, Clarke L, Sabo R, Cutler DL. Huhn RD, et al. Among authors: radwanski e. Immunopharmacology. 1999 Feb;41(2):109-17. doi: 10.1016/s0162-3109(98)00058-7. Immunopharmacology. 1999. PMID: 10102792 Clinical Trial.

6

Disposition of recombinant human interleukin-10 in subjects with various degrees of renal function.

Andersen SR, Lambrecht LJ, Swan SK, Cutler DL, Radwanski E, Affrime MB, Garaud JJ. Andersen SR, et al. Among authors: radwanski e. J Clin Pharmacol. 1999 Oct;39(10):1015-20. doi: 10.1177/00912709922011773. J Clin Pharmacol. 1999. PMID: 10516935 Clinical Trial.

7

Pharmacokinetics and leukocyte responses of recombinant human interleukin-10.

Radwanski E, Chakraborty A, Van Wart S, Huhn RD, Cutler DL, Affrime MB, Jusko WJ. Radwanski E, et al. Pharm Res. 1998 Dec;15(12):1895-901. doi: 10.1023/a:1011918425629. Pharm Res. 1998. PMID: 9892475 Clinical Trial.

8

Differential plasma duration of antiplatelet-activating factor and antihistamine activities of oral Sch 37370 in humans.

Billah MM, Gilchrest HG, Eckel SP, Granzow CA, Lawton PJ, Radwanski E, Brannan MD, Affrime MB, Christopher JD, Richards W, et al. Billah MM, et al. Among authors: radwanski e. Clin Pharmacol Ther. 1992 Aug;52(2):151-9. doi: 10.1038/clpt.1992.124. Clin Pharmacol Ther. 1992. PMID: 1505150 Clinical Trial.

9

Pharmacokinetics of flutamide in patients with renal insufficiency.

Anjum S, Swan SK, Lambrecht LJ, Radwanski E, Cutler DL, Affrime MB, Halstenson CE. Anjum S, et al. Among authors: radwanski e. Br J Clin Pharmacol. 1999 Jan;47(1):43-7. doi: 10.1046/j.1365-2125.1999.00831.x. Br J Clin Pharmacol. 1999. PMID: 10073738 Free PMC article.

10

Secretion of dilevalol in breast milk.

Radwanski E, Nagabhushan N, Affrime MB, Perentesis G, Symchowicz S, Patrick JE. Radwanski E, et al. J Clin Pharmacol. 1988 May;28(5):448-53. doi: 10.1002/j.1552-4604.1988.tb05758.x. J Clin Pharmacol. 1988. PMID: 2899094

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters